These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 25681668)
1. The synergistic effect of combination temozolomide and chloroquine treatment is dependent on autophagy formation and p53 status in glioma cells. Lee SW; Kim HK; Lee NH; Yi HY; Kim HS; Hong SH; Hong YK; Joe YA Cancer Lett; 2015 May; 360(2):195-204. PubMed ID: 25681668 [TBL] [Abstract][Full Text] [Related]
2. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381 [TBL] [Abstract][Full Text] [Related]
3. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells. Hori YS; Hosoda R; Akiyama Y; Sebori R; Wanibuchi M; Mikami T; Sugino T; Suzuki K; Maruyama M; Tsukamoto M; Mikuni N; Horio Y; Kuno A J Neurooncol; 2015 Mar; 122(1):11-20. PubMed ID: 25528635 [TBL] [Abstract][Full Text] [Related]
4. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro. Ryabaya OO; Inshakov AN; Egorova AV; Emelyanova MA; Nasedkina TV; Zasedatelev AS; Khochenkov DA; Stepanova EV Anticancer Drugs; 2017 Mar; 28(3):307-315. PubMed ID: 27941537 [TBL] [Abstract][Full Text] [Related]
5. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner. Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979 [TBL] [Abstract][Full Text] [Related]
6. Targeting autophagy to sensitive glioma to temozolomide treatment. Yan Y; Xu Z; Dai S; Qian L; Sun L; Gong Z J Exp Clin Cancer Res; 2016 Feb; 35():23. PubMed ID: 26830677 [TBL] [Abstract][Full Text] [Related]
7. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Torres S; Lorente M; Rodríguez-Fornés F; Hernández-Tiedra S; Salazar M; García-Taboada E; Barcia J; Guzmán M; Velasco G Mol Cancer Ther; 2011 Jan; 10(1):90-103. PubMed ID: 21220494 [TBL] [Abstract][Full Text] [Related]
8. Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells. Hirose Y; Berger MS; Pieper RO Cancer Res; 2001 Aug; 61(15):5843-9. PubMed ID: 11479224 [TBL] [Abstract][Full Text] [Related]
9. Autophagy inhibition potentiates SAHA‑mediated apoptosis in glioblastoma cells by accumulation of damaged mitochondria. Lohitesh K; Saini H; Srivastava A; Mukherjee S; Roy A; Chowdhury R Oncol Rep; 2018 Jun; 39(6):2787-2796. PubMed ID: 29658588 [TBL] [Abstract][Full Text] [Related]
10. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo. Chakrabarti M; Ray SK Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275 [TBL] [Abstract][Full Text] [Related]
11. p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Hirose Y; Berger MS; Pieper RO Cancer Res; 2001 Mar; 61(5):1957-63. PubMed ID: 11280752 [TBL] [Abstract][Full Text] [Related]
12. Impact of autophagy inhibition at different stages on cytotoxic effect of autophagy inducer in glioblastoma cells. Li C; Liu Y; Liu H; Zhang W; Shen C; Cho K; Chen X; Peng F; Bi Y; Hou X; Yang Z; Zheng Z; Wang K; Wang X; Zhang J; Zhong C; Zou H; Zhang X; Zhao S Cell Physiol Biochem; 2015; 35(4):1303-16. PubMed ID: 25721868 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy. Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224 [TBL] [Abstract][Full Text] [Related]
14. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas. Gonçalves RM; Agnes JP; Delgobo M; de Souza PO; Thomé MP; Heimfarth L; Lenz G; Moreira JCF; Zanotto-Filho A Biochem Pharmacol; 2019 May; 163():440-450. PubMed ID: 30878553 [TBL] [Abstract][Full Text] [Related]
15. Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling. Han S; Meng L; Jiang Y; Cheng W; Tie X; Xia J; Wu A Br J Cancer; 2017 May; 116(10):1302-1311. PubMed ID: 28359080 [TBL] [Abstract][Full Text] [Related]
16. Cobalt chloride treatment induces autophagic apoptosis in human glioma cells via a p53-dependent pathway. Cheng BC; Chen JT; Yang ST; Chio CC; Liu SH; Chen RM Int J Oncol; 2017 Mar; 50(3):964-974. PubMed ID: 28197638 [TBL] [Abstract][Full Text] [Related]
17. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide? He Y; Kaina B Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722 [TBL] [Abstract][Full Text] [Related]
18. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition. Zhang P; Sun S; Li N; Ho ASW; Kiang KMY; Zhang X; Cheng YS; Poon MW; Lee D; Pu JKS; Leung GKK J Neurooncol; 2017 May; 132(3):393-400. PubMed ID: 28293765 [TBL] [Abstract][Full Text] [Related]
19. β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells. Wang N; Zhang Q; Luo L; Ning B; Fang Y J Cell Physiol; 2018 Mar; 233(3):2434-2443. PubMed ID: 28776671 [TBL] [Abstract][Full Text] [Related]
20. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. Zhang WB; Wang Z; Shu F; Jin YH; Liu HY; Wang QJ; Yang Y J Biol Chem; 2010 Dec; 285(52):40461-71. PubMed ID: 20880848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]